ABBV vs LLY: Side-by-Side Comparison
Compare Abbvie Inc (ABBV) and Lilly(Eli) & Company (LLY) side by side: market cap USD 461.26B vs USD 1.08T, P/E 128.8 vs 43.7. Financials, growth and model signals on Bullrun.
| Metric | ABBV | LLY |
|---|---|---|
| Company | Abbvie Inc | Lilly(Eli) & Company |
| Country / Exchange | United States · NYSE | United States · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-General | Drug Manufacturers-General |
| Market cap | USD 461.26B | USD 1.08T |
| P/E ratio | 128.8 | 43.7 |
| Dividend yield | 2.58% | 0.53% |
| Valuation model | 66.8% overvalued | 11.4% overvalued |
| Revenue (FY2025) | USD 61.16B | USD 65.18B |
| Revenue growth YoY | +8.6% | +44.7% |
| Net income | USD 4.23B | USD 20.64B |
| Gross margin | 70.2% | 83.0% |
| Diluted EPS | 2.36 | 22.95 |